The angiogenic switch is triggered by tumour growth which creates a hypoxic and acidic environment, promoting release of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and development of new blood vessels and endothelial cell migration via integrins [1]. Here, VEGFA is linked to neoplasm.